A decreasing trend within 10-year period, from 25,24 million € in 2010 to 15,47 million € in 2019 was observed (12.6%), although considering absolute costs in Euros, a larger sum invested in breast cancer patients was used for therapy comparing with the funds invested in diagnostics.
← all excerpts
Medical cost of breast cancer services in Serbia between 2010 and 2019: national data report.
1
—
—